The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Davis Stephen since year 2005.
The trader's CIK number is 1131146.
At the time of the last reporting, Davis Stephen was the CEO of Acadia Pharmaceuticals Inc .
(stock ticker symbol ACAD).
See this page for all insider trading activities at Acadia Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-10-15||ACAD||Acadia Pharmaceuticals Inc||Option Ex||5,937||.00||0|
|2019-10-15||ACAD||Acadia Pharmaceuticals Inc||Sale||2,983||39.65||118,275|
|2019-10-09||ACAD||Acadia Pharmaceuticals Inc||Option Ex||29,792||19.65||585,412|
|2019-10-10||ACAD||Acadia Pharmaceuticals Inc||Option Ex||120,208||19.65||2,362,087|
|2019-10-09||ACAD||Acadia Pharmaceuticals Inc||Sale||29,792||40.00||1,191,709|
|2019-10-10||ACAD||Acadia Pharmaceuticals Inc||Sale||120,208||40.19||4,831,039|
|2014-09-26||HRTX||Heron Therapeutics, Inc. /de/||Option Ex||120,313||7.20||866,253|
|2012-01-06||RDEA||Intrabiotics Pharmaceuticals Inc /de||Sale||700||15.91||11,137|
|2011-11-15||RDEA||Intrabiotics Pharmaceuticals Inc /de||Sale||432||18.86||8,145|
|2011-10-06||RDEA||Intrabiotics Pharmaceuticals Inc /de||Sale||700||15.43||10,803|
|2011-07-06||RDEA||Intrabiotics Pharmaceuticals Inc /de||Sale||700||25.65||17,957|
|2011-05-16||RDEA||Intrabiotics Pharmaceuticals Inc /de||Sale||335||25.67||8,600|
|2011-04-08||RDEA||Intrabiotics Pharmaceuticals Inc /de||Sale||3,000||28.20||84,594|
|2010-11-22||RDEA||Intrabiotics Pharmaceuticals Inc /de||Sale||351||21.92||7,692|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Davis Stephen (CEO of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.